Why Elevance (ELV) is a Smart Addition to Your Portfolio Now - MSN

Why Elevance (ELV) is a Smart Addition to Your Portfolio Now. 4mo. Elevance Health, Inc. ELV is strategically poised for growth, driven by increasing memberships in individual commercial risk ...

CouponFollow Extension

$118
OFF

Why Elevance (ELV) Is A Smart Addition To Your Portfolio Now

1 week from now

Mar 15, 2024 · Elevance, with a market capitalization of $118.6 billion, is a major health benefits company in the United States. Due to solid prospects, this currently Zacks Rank #2 (Buy) …

yahoo.com

$114
OFF

Here's Why You Should Add Elevance Health Stock To Your Portfolio

1 week from now

Oct 9, 2024 · Elevance Health — with a market cap of $114.2 billion — is a major health benefits company. Courtesy of solid prospects, this Zacks Rank #2 (Buy) stock is worth adding to your …

yahoo.com

5%
OFF

Here's Why You Should Add Elevance Health Stock To Your Portfolio

1 week from now

Oct 9, 2024 · Let’s delve deeper. ELV's One-Year Price Performance. Shares of Elevance Health have gained 7.5% in the past year, outperforming the industry’s 6.4% growth. Image Source: …

nasdaq.com

5%
OFF

Here's Why You Should Hold Elevance (ELV) In Your Portfolio

1 week from now

May 22, 2023 · Key Concerns. There are a few factors that are impeding the stock’s growth lately. ELV’s total expenses rose 10.5% in the first quarter of 2023, mainly due to higher benefit …

nasdaq.com

$483.00
OFF

Wells Fargo Reaffirms Their Buy Rating On Elevance Health (ELV)

1 week from now

1 day ago · In a report released today, Steve Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target of $483.00. The company’s …

businessinsider.com

5%
OFF

Why Elevance Health (ELV) Is A Top Value Stock For The Long-Term

1 week from now

Feb 21, 2023 · From inception in 2012 through November, the Zacks Top 10 Stocks portfolio has tripled the market, gaining an impressive +884.5% versus the S&P 500’s +287.4%. Our …

nasdaq.com

$114
OFF

Here's Why You Should Add Elevance Health Stock To Your …

1 week from now

Elevance Health — with a market cap of $114.2 billion — is a major health benefits company. Courtesy of solid prospects, this Zacks Rank #2 (Buy) stock is worth adding to your portfolio at …

msn.com

100%
OFF

Elevance Health (ELV) Earnings Date And Reports 2024 - MarketBeat

1 week from now

4 days ago · Elevance Health (NYSE:ELV) has a trailing price-to-earnings ratio of 14.59 and a forward price-to-earnings ratio of 12.14. ... Act now - Request your 100% free, wealth …

marketbeat.com

20%
OFF

Elevance Health Declines 20% In 3 Months: Time To Sell The Stock?

1 week from now

6 days ago · Elevance Health, Inc.’s ELV shares have lost 20% in the past three months compared with the industry’s 7.1% decline. It has also lagged the broader Zacks Medical …

yahoo.com

FAQs about Why Elevance (ELV) is a Smart Addition to Your Portfolio Now - MSN Coupon?

Is Elevance health (Elv) a good stock to buy?

Elevance Health, Inc. ELV is well-poised to grow on the back of Carelon’s business strength and commercial member growth. The company keeps expanding its operating margins for both Health Benefits and Carelon units, which positions it for improving profits. Elevance Health — with a market cap of $114.2 billion — is a major health benefits company. ...

Why did Elevance health acquire ELV?

These acquisitions help Elevance Health expand its market presence, diversify revenue streams, and strengthen its offerings in Medicare Advantage and Medicaid services. Premium rate increases and product expansions will continue to support ELV’s growth trajectory. ...

Is Elevance (Elv) a good stock to buy in 2024?

The Zacks Consensus Estimate for ELV’s 2024 earnings is pegged at $37.14 per share, indicating 12.1% year-over-year growth. The company witnessed one upward estimate revision over the past 30 days against no movement in the opposite direction. Elevance beat on earnings in each of the last four quarters, with an average surprise of 3.1%. ...

Did Elevance health (ELV) miss earnings estimate?

In the previous quarter, Elevance Health (NYSE:ELV) missed the analysts' consensus estimate of $9.66 by $1.29 with a reported earnings per share (EPS) of $8.37. Learn more on analysts' earnings estimate vs. ELV's actual earnings. How can I listen to Elevance Health's earnings conference call? ...

Is ELV (Elv) a good stock to buy?

Despite growth in stock price, ELV is trading at a discount compared to the industry average. The company's forward 12-month price-to-earnings (P/E) ratio stands at 12.04X, below the industry average of 14.78X, indicating undervaluation. The company has a Value Score of A. Hence, this is an attractive option to retain in an investment portfolio. ...

Is Elevance's top line poised to gain from rising revenues?

Additionally, the expansion of memberships in dental and vision lines will contribute significantly to this positive trend. Elevance's (ELV) top line is poised to gain from rising product revenues, administrative fees and other revenues. ...